Psychiatr Serv 55:886-891, August 2004
© 2004 American Psychiatric Association
Partial Compliance and Risk of Rehospitalization Among California Medicaid Patients With Schizophrenia
Peter J. Weiden, M.D.,
Chris Kozma, Ph.D.,
Amy Grogg, Pharm.D. and
Julie Locklear, Pharm.D., M.B.A.
OBJECTIVE: The objective of this study was to evaluate the relationship between compliance with an antipsychotic medication regimen and risk of hospitalization in a cohort of California Medicaid patients with schizophrenia. METHODS: Compliance behavior was estimated by using a retrospective review of California Medicaid pharmacy refill and medical claims for 4,325 outpatients for whom antipsychotics were prescribed for treatment of schizophrenia from 1999 to 2001. Compliance behavior was estimated by using four different definitions: gaps in medication therapy, medication consistency and persistence, and a medication possession ratio. Patients were followed for one year and had an average of 19.1 dispensing events. Logistic regression models using each compliance estimate were used to determine the odds of hospitalization. RESULTS: Risk of hospitalization was significantly correlated with compliance. With all definitions, lower compliance was associated with a greater risk of hospitalization over and above any other risk factors for hospitalization. For example, the presence of any gap in medication coverage was associated with increased risk of hospitalization, including gaps as small as one to ten days (odds ratio [OR]=1.98). A gap of 11 to 30 days was associated with an OR of 2.81, and a gap of more than 30 days was associated with an OR of 3.96. CONCLUSIONS: This study showed a direct correlation between estimated partial compliance and hospitalization risk among patients with schizophrenia across a continuum of compliance behavior.
This article has been cited by other articles:
|
|
|
|
 
J. C. West, S. C. Marcus, J. Wilk, L. M. Countis, D. A. Regier, and M. Olfson
Use of Depot Antipsychotic Medications for Medication Nonadherence in Schizophrenia
Schizophr Bull,
September 1, 2008;
34(5):
995 - 1001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams
Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change
Health Aff.,
May 1, 2008;
27(3):
w185 - w195.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Taylor, A. Currie, K. Lloyd, M. Price, and K. Peperell
Impact of risperidone long acting injection on resource utilization in psychiatric secondary care
J Psychopharmacol,
March 1, 2008;
22(2):
128 - 131.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. C. Marcus and M. Olfson
Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
Schizophr Bull,
January 1, 2008;
34(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Phillips McEnany
Psychopharmacologic Strategies and Associated Challenges in the Long-Term Treatment of Schizophrenia
Journal of the American Psychiatric Nurses Association,
November 1, 2007;
13(5_suppl):
S6 - S15.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Olfson, S. C. Marcus, and H. Ascher-Svanum
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Schizophr Bull,
November 1, 2007;
33(6):
1379 - 1387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, M. Wang, P. Diamond, D. C. Glahn, D. Castillo, S. Bendle, Y. W. F. Lam, L. Ereshefsky, and A. L. Miller
Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications
Psychiatr Serv,
September 1, 2007;
58(9):
1187 - 1192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Mitchell and T. Selmes
Why don't patients take their medicine? Reasons and solutions in psychiatry
Advan. Psychiatr. Treat.,
September 1, 2007;
13(5):
336 - 346.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. KEKS, M. INGHAM, A. KHAN, and K. KARCHER
Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder: Randomised, controlled, open-label study
The British Journal of Psychiatry,
August 1, 2007;
191(2):
131 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Byerly, A. Thompson, T. Carmody, R. Bugno, T. Erwin, M. Kashner, and A. J. Rush
Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia
Psychiatr Serv,
June 1, 2007;
58(6):
844 - 847.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Woltmann, M. Valenstein, D. E. Welsh, T. A. Lee, P. A. Wolschon, J. Grabowski, and P. A. Reilly
Using Pharmacy Data on Partial Adherence to Inform Clinical Care of Patients With Serious Mental Illness
Psychiatr Serv,
June 1, 2007;
58(6):
864 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. West, J. E. Wilk, I. L. Muszynski, D. S. Rae, M. Rubio-Stipec, C. L. Alter, W. E. Narrow, and D. A. Regier
Medication Access and Continuity: The Experiences of Dual-Eligible Psychiatric Patients During the First 4 Months of the Medicare Prescription Drug Benefit
Am J Psychiatry,
May 1, 2007;
164(5):
789 - 796.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Lauriello
Great(er) Expectations
Am J Psychiatry,
March 1, 2007;
164(3):
377 - 379.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Piette, M. Heisler, D. Ganoczy, J. F. McCarthy, and M. Valenstein
Differential Medication Adherence Among Patients With Schizophrenia and Comorbid Diabetes and Hypertension
Psychiatr Serv,
February 1, 2007;
58(2):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Katz, S. Kripalani, and B. D. Weiss
Use of pictorial aids in medication instructions: A review of the literature
Am. J. Health Syst. Pharm.,
December 1, 2006;
63(23):
2391 - 2397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. I. Velligan, Y.-W. F. Lam, D. C. Glahn, J. A. Barrett, N. J. Maples, L. Ereshefsky, and A. L. Miller
Defining and Assessing Adherence to Oral Antipsychotics: A Review of the Literature
Schizophr Bull,
October 1, 2006;
32(4):
724 - 742.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M Hess, M. A Raebel, D. A Conner, and D. C Malone
Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures
Ann. Pharmacother.,
July 1, 2006;
40(7):
1280 - 1288.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Compton, B. E. Rudisch, J. Craw, T. Thompson, and D. A. Owens
Predictors of Missed First Appointments at Community Mental Health Centers After Psychiatric Hospitalization
Psychiatr Serv,
April 1, 2006;
57(4):
531 - 537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Mohl, K. Westlye, S. Opjordsmoen, A. Lex, A. Schreiner, M. Benoit, P. Braunig, and R. Medori
Long-acting risperidone in stable patients with schizoaffective disorder
J Psychopharmacol,
September 1, 2005;
19(5_suppl):
22 - 31.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. J. Weiden and N. Rao
Teaching Medication Compliance to Psychiatric Residents: Placing an Orphan Topic Into a Training Curriculum
Acad Psychiatry,
June 1, 2005;
29(2):
203 - 210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. J. Keith, L. Pani, B. Nick, R. Emsley, L. San, M. Turner, R. Conley, P. Scully, P. S. Chue, and B. Lachaux
Practical Application of Pharmacotherapy With Long-Acting Risperidone for Patients With Schizophrenia
Psychiatr Serv,
September 1, 2004;
55(9):
997 - 1005.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Medication Compliance in Schizophrenia: Small Compliance Gaps Count
Journal Watch Psychiatry,
August 19, 2004;
2004(819):
6 - 6.
[Full Text]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
